Founders Financial Securities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Founders Financial Securities's LLY Position: Q3 2026 in Review
Founders Financial Securities increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $236K and bringing the position to 1,369 shares worth $1.58M. The position accounts for 0.08% of the portfolio, ranked #241.
Founders Financial Securities first reported a position in LLY in Q4 2013 and has held it in 23 quarters since. The position peaked at $2.95M in Q4 2014. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Founders Financial Securities held 1,369 shares of Eli Lilly worth $1.58M as of Q3 2026.
- Founders Financial Securities bought 200 Eli Lilly shares in Q3 2026, an estimated $236K.
- Eli Lilly made up 0.08% of Founders Financial Securities's portfolio in Q3 2026, its #241 holding.
- Founders Financial Securities first reported a position in Eli Lilly in Q4 2013 and has held it in 23 quarters since.
- Founders Financial Securities's Eli Lilly position peaked at $2.95M in Q4 2014.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Founders Financial Securities's 13F filing for Q3 2026, filed 28 Oct 2026.